Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy.

Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy.
复制标题

DOI:
10.36141/svdld.v37i2.9599
复制
发表时间:
2020
期刊:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
影响因子:
--
通讯作者:
Sweiss NJ
Sweiss NJ
中科院分区:
其他
文献类型:
--
作者:
Syed H;Ascoli C;Linssen CF;Vagts C;Iden T;Syed A;Kron J;Polly K;Perkins D;Finn PW;Novak R;Drent M;Baughman R;Sweiss NJ

文献摘要

参考文献

被引文献

相似文献

结节病是一种全身性炎症性疾病,其特征是受影响器官中形成肉芽肿,是由对未知抗原的免疫反应失调引起的。接受免疫抑制药物的结节病患者感染的风险增加。淋巴细胞减少症也常见于结节病患者。在本次综述中,将概述感染风险,包括机会性感染。还将总结基于文献综述的疫苗接种和预防性治疗建议。 (结节病血管弥漫性肺疾病 2020;37(2):87-98)。
Sarcoidosis is a systemic inflammatory disease characterized by granuloma formation in affected organs and caused by dysregulated immune response to an unknown antigen. Sarcoidosis patients receiving immunosuppressive medications are at increased risk of infection. Lymphopenia is also commonly seen among patient with sarcoidosis. In this review, risk of infections, including opportunistic infections, will be outlined. Recommendations for vaccinations and prophylactic therapy based on literature review will also be summarized. (Sarcoidosis Vasc Diffuse Lung Dis 2020; 37 (2): 87-98).
DOI: 10.1002/art.11137
发表时间: 2003-08-01
影响因子: --
作者:
Gómez-Reino, JJ;Carmona, L;Montero, MD
通讯作者: Montero, MD
DOI: 10.1093/rheumatology/kem076
发表时间: 2007-07-01
期刊: RHEUMATOLOGY
影响因子: 5.5
作者:
Bernatsky, S.;Hudson, M.;Suissa, S.
通讯作者: Suissa, S.
DOI: 10.1007/s10875-017-0469-4
发表时间: 2018-02-01
影响因子: 9.1
作者:
Edgar, John David M.;Richter, Alex G.;Sorensen, Ricardo U.
通讯作者: Sorensen, Ricardo U.
DOI: 10.1136/annrheumdis-2013-203407
发表时间: 2014-11-01
影响因子: 27.4
作者:
Baddley, John W.;Winthrop, Kevin L.;Curtis, Jeffrey R.
通讯作者: Curtis, Jeffrey R.
DOI: 10.1001/jamanetworkopen.2018.4169
发表时间: 2018-11-01
期刊: JAMA NETWORK OPEN
影响因子: 13.8
作者:
Barmettler, Sara;Ong, Mei-Sing;Walter, Jolan
通讯作者: Walter, Jolan